Note 12 - Share-based Compensation

12 Months Ended

Dec. 31, 2021

Notes to Financial Statements

Share-based Payment Arrangement [Text Block]

We have granted shares of Company common stock, restricted Company common stock and restricted stock units to employees, consultants and non-employee directors under our 2017 Omnibus Incentive Plan.

Total share-based compensation consisted of the following (in thousands):

	Year Ended
	December 31,
	2021			2020
Share-based compensation:
Equity awards	$	(4,541	)	$	(155	)
Liability awards		—			—
Total share-based compensation		(4,541	)		(155	)
Capitalized share-based compensation		228			(186	)
Total share-based compensation expense	$	(4,313	)	$	(341	)

Certain employee arrangements provided for cash bonuses upon a positive FID in the Terminal (the “FID Bonus”). In January 2018, the Compensation Committee of the Board of Directors approved, and certain employees party to such arrangements accepted, an amendment to such arrangements whereby the FID Bonuses would be settled in shares of Company common stock equal to 110% of the FID Bonus. The associated liability for FID Bonuses to be settled in shares of Company common stock of $0.2 million is included in share-based compensation liability in our Consolidated Balance Sheets at each of  December 31, 2021 and 2020.

The total unrecognized compensation costs at  December 31, 2021 relating to equity-classified awards were $25.1 million, which is expected to be recognized over a weighted average period of 3 years.

Restricted stock awards are awards of Company common stock that are subject to restrictions on transfer and to a risk of forfeiture if the recipient’s employment with the Company is terminated prior to the lapse of the restrictions. Restricted stock awards vest based on service conditions and/or performance conditions. The amortization of the value of restricted stock grants is accounted for as a charge to compensation expense, or capitalized, depending on the nature of the services provided by the employee, with a corresponding increase to additional-paid-in-capital over the requisite service period.

Grants of restricted stock to employees, non-employees and non-employee directors that vest based on service and/or performance conditions are measured at the closing quoted market price of our common stock on the grant date. 

The table below provides a summary of our restricted stock awards outstanding as of  December 31, 2021 and changes during the year ended  December 31, 2021 (in thousands, except for per share information):

	Shares			Weighted Average Grant Date Fair Value Per Share
Non-vested at January 1, 2021		3,511		$	8.05
Granted		1,312			2.80
Vested		(660	)		5.50
Forfeited		(1,125	)		9.21
Non-vested at December 31, 2021		3,038		$	5.88

The table below provides a summary of our restricted stock units outstanding as of  December 31, 2021 and changes during the year ended  December 31, 2021 (in thousands, except for per share information):

	Shares			Weighted Average Grant Date Fair Value Per Share
Non-vested at January 1, 2021		—			—
Granted		7,154			3.31
Vested		—			—
Forfeited		(50	)		3.31
Non-vested at December 31, 2021		7,104		$	3.31